Idexx Laboratories
IDXX
697 hedge funds and large institutions have $18.7B invested in Idexx Laboratories in 2018 Q3 according to their latest regulatory filings, with 81 funds opening new positions, 219 increasing their positions, 272 reducing their positions, and 39 closing their positions.
108% more first-time investments, than exits
New positions opened: 81 | Existing positions closed: 39
7% more capital invested
Capital invested by funds: $17.5B → $18.7B (+$1.25B)
5% more funds holding
Funds holding: 664 → 697 (+33)
1% more call options, than puts
Call options by funds: $52.8M | Put options by funds: $52.4M
0% more funds holding in top 10
Funds holding in top 10: 23 → 23 (0)
5.68% less ownership
Funds ownership: 92.32% → 86.63% (-5.7%)
19% less repeat investments, than reductions
Existing positions increased: 219 | Existing positions reduced: 272
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$87.9M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
+$79.8M |
| 3 |
Jennison Associates
New York
|
+$51.7M |
| 4 |
State Street
Boston,
Massachusetts
|
+$45M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$37.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$95.1M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$58.1M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$54.6M |
| 4 |
Two Sigma Investments
New York
|
-$53.7M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$50.7M |
IDXX Hedge Fund Activity: Q3 2018 in Review
697 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q3 2018, worth a combined $18.7B — up 7.2% from $17.5B a quarter earlier.
Buyers outnumbered sellers: 81 funds opened new IDXX positions and 39 closed out — a net gain of 42 holders — while 219 added to existing stakes and 272 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $87.9M. The largest seller was Renaissance Technologies, cutting an estimated $95.1M.
- 697 institutional investors held Idexx Laboratories (IDXX) as of Q3 2018, up from 664 in Q2 2018.
- Funds reported $18.7B of Idexx Laboratories stock for Q3 2018, up 7.2% quarter-over-quarter.
- 81 funds opened new Idexx Laboratories positions in Q3 2018 and 39 closed out, a net change of +42 holders.
- The largest Idexx Laboratories buyer in Q3 2018 was Goldman Sachs, an estimated $87.9M added.
- The largest Idexx Laboratories seller in Q3 2018 was Renaissance Technologies, an estimated $95.1M sold.
Based on aggregated 13F filings for Q3 2018.